DEC 23, 2016 1:52 PM PST

Hypertension Drug May be Effective at Blocking Cancer

WRITTEN BY: Xuan Pham

Calcium channel blockers are effective at reducing blood pressure, but new research suggest these drugs may also block cancer cell invasion.

Image credit: Pixabay.com

The discovery that a previously approved drug may also have other beneficial uses is always a welcome one. When this happens, the testing and approval process could theoretically pass much quicker, lessening the cost burden while making the therapy more easily accessible to patients. As such, researchers have put renewed focus on finding new uses for old drugs.

This plan of attack was exactly how the team from the University of Turku, Finland landed on calcium channel blockers. In particular, the team found that these drugs, which are typically prescribed to treat hypertension, can block metastasis of pancreatic and breast cancer cells in culture.

“Identification of anti-hypertension drugs as potential therapeutics against breast and pancreatic cancer metastasis was a big surprise. The targets of these drugs were not known to be present in cancer cells and therefore no one had considered the possibility that these drugs might be effective against aggressive cancer types” said Johanna Ivaska, the study’s senior author.

When they investigated further, the team found that FDA-approved calcium channel blockers block the formation of filopodia - tendril-like structures that extend from the main tumor. These help the cancer cells gauge their environment and, if conditions are right, help the cancer cell migrate to new places.

“Myosin-10 expressing cancers have a large number of structures called filopodia. They are sticky finger-like structures the cancer cells extend to sense their environment and to navigate -- imagine a walking blind spider,” said Guillaume Jacquemet, the study’s lead author. The presence of L-type calcium channel blockers seem to inhibit these structures and  stop cancer cell migration and invasion.

The results suggest a new clinical pathway by which scientists can target Myosin-10-positive cancers. Furthermore, it opens the door for future investigation of other relevant channels which may also have a function in cancer growth.

“Altogether we uncover a novel and clinically relevant signalling pathway that regulates filopodia formation in cancer cells and propose that cycles of filopodia stabilization, followed by maturation into focal adhesions, directs cancer cell migration and invasion,” the team wrote in their paper, published in Nature Communications.

However, before cancer patients can be prescribed calcium-channel blocker drugs like Amlodipine, Felodipine, or Nifedipine, they will have to wait for further validation studies. In the next phase, Ivaska’s team plan on testing the drugs in mouse models and combing through patient data. Promising results at that phase may then lead to clinical trials to confirm the safety and efficacy of calcium channel blockers in cancer patients.

Additional sources: University of Turku

About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
SEP 12, 2020
Cancer
Treating cancer with the botanical andrographis
SEP 12, 2020
Treating cancer with the botanical andrographis
A study from City of Hope published in the journal Carcinogenesis reports that the use of the natural botanical And ...
SEP 23, 2020
Cancer
Can Increased Pain Indicate Oral Cancer?
SEP 23, 2020
Can Increased Pain Indicate Oral Cancer?
The human body has many ways of letting you know something is wrong. It can send signals to tell you that you are hungry ...
SEP 30, 2020
Cancer
Chemokines Could be the Key in Controlling Glioma Stem Cells
SEP 30, 2020
Chemokines Could be the Key in Controlling Glioma Stem Cells
The transformation of a healthy cell into a cancerous one often comes with a slew of cellular signaling changes.  T ...
OCT 08, 2020
Immunology
Immuno Metabolic Complexity and Modulating Metabolites
OCT 08, 2020
Immuno Metabolic Complexity and Modulating Metabolites
Immunometabolism is a relatively new subspecialty of immunology as we’ve begun to unravel the complex metabolic re ...
OCT 28, 2020
Cancer
Protecting the Head and Neck from Off Target Radiation
OCT 28, 2020
Protecting the Head and Neck from Off Target Radiation
Radiotherapy alone or with chemotherapy is the go-to treatment for head and neck cancers. Unfortunately, head and neck t ...
NOV 19, 2020
Cancer
New technique to synthesize phenazines offers hope for cancer treatments
NOV 19, 2020
New technique to synthesize phenazines offers hope for cancer treatments
Research from Tokyo University of Science investigators highlights new accomplishments in the fight against cancer. The ...
Loading Comments...